BioSpace News Archive

Lyme Disease Treatment Market: Rise in Prevalence of Lyme Disease to Propel Market

According to the report, the global Lyme disease treatment market was valued at US$ 1.58 Bn in 2020 and is projected to expand at a CAGR of ~6% from 2021 to 2031.

June 21, 2021
·
5 min read
Anti-Snoring Treatment Has Become Highly Sought-after to Curb Rising Cases of Sleep Apnea: Fact.MR

As per a study by Fact.MR, the global anti-snoring treatment market is expected to surpass a valuation of US$ 8.6 billion by the year 2031.

June 21, 2021
·
5 min read
Active Pharmaceutical Ingredients [API] Market: Branded or Innovative Prescription Drugs to be Highly Lucrative

According to the report, the global active pharmaceutical ingredients market was valued at US$ 168 Bn in 2020 and is projected to expand at a CAGR of ~6% from 2021 to 2031.

June 21, 2021
·
8 min read
Drug Development

Albireo Announces Expanded Phase 3 Data on Bylvay™ (odevixibat) and A3907 at Upcoming EASL International Liver Congress

Albireo Pharma, Inc., a clinical-stage rare liver disease company developing novel bile acid modulators, announced new data in nine accepted abstracts to be presented at EASL International Liver Congress™ 2021 on June 23 – 26.

June 21, 2021
·
15 min read
Why 5G Enabled Healthcare Is Important For Patients and Spatial Computing

5G is the fifth generation of cellular wireless technology, which can offer massive connection power and fast internet speed for data transfer.

June 21, 2021
·
3 min read
Drug Development

Tarsus Pharmaceuticals, Inc. Announces Positive Results of Saturn-1 Pivotal Trial Evaluating TP-03 for the Treatment of Demodex Blepharitis

Tarsus Pharmaceuticals, Inc. announced that all pre-specified primary and secondary endpoints were met for its pivotal Phase 2b/3 Saturn-1 trial evaluating the company’s novel investigational therapeutic, TP-03, in patients with Demodex blepharitis.

June 21, 2021
·
14 min read
Biotech Bay

Rafael Holdings Announces Strategic Merger with Rafael Pharmaceuticals to Form a Focused Late-Stage Clinical Oncology Company

Rafael Holdings, Inc., announced that it has entered into a merger agreement with Rafael Pharmaceuticals, Inc., a privately held, late-stage clinical oncology company focused on cancer metabolism-based therapeutics.

June 21, 2021
·
7 min read
Pharm Country

Quest Diagnostics Releases Annual Corporate Responsibility Report

Quest Diagnostics Incorporated, the world’s leading provider of diagnostic information services, released the Annual Corporate Responsibility Report for 2020.

June 21, 2021
·
2 min read
Significant Discovery Reveals New Antiviral Properties of Tetra Bio-Pharma’s Innovative Drug ARDS-003

Tetra Bio-Pharma Inc., a leader in cannabinoid-derived drug discovery and development announced that its investigational new drug ARDS-003 has been studied in a viral infected organoid model as part of a research collaboration between Targeted Pharmaceuticals and George Mason University.

June 21, 2021
·
7 min read
Bio NC

Aerie Pharmaceuticals to Participate in the Raymond James Human Health Innovation Conference – UPDATED RELEASE

Aerie Pharmaceuticals, Inc. announced that Vicente Anido, Jr., Ph.D., Chairman and Chief Executive Officer, will present in a fireside discussion at the Raymond James Human Health Innovation Conference on Tuesday, June 22, 2021 at 1:20 p.m. Eastern Time.

June 21, 2021
·
2 min read